Juan Liberal-Martin
Fulham Road
London, ENG SW36JJ, United Kingdom
London, ENG SW36JJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib.
Journal: Melanoma research
Published: December 20, 2015
BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma.
Journal: Expert opinion on pharmacotherapy
Published: May 23, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 05, 2015
Safety of pembrolizumab for the treatment of melanoma.
Journal: Expert opinion on drug safety
Published: May 01, 2015
Vemurafenib for the treatment of BRAF mutant metastatic melanoma.
Journal: Future oncology (London, England)
Published: February 17, 2015
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report.
Journal: Cancer immunology, immunotherapy : CII
Published: February 02, 2015
Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?
Journal: Expert review of anticancer therapy
Published: January 15, 2015
First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.
Journal: Clinical sarcoma research
Published: January 06, 2015
Trabectedin for advanced soft tissue sarcomas: optimizing use.
Journal: Therapeutics and clinical risk management
Published: December 26, 2014
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.
Journal: Clinical sarcoma research
Published: November 21, 2014
Targeting protein kinase C in sarcoma.
Journal: Biochimica et biophysica acta
Published: June 17, 2014
New RAF kinase inhibitors in cancer therapy.
Journal: Expert opinion on pharmacotherapy
Published: April 29, 2014
Last Updated: 09/26/2026